Catherine Argyriou, PhD, MS

Assistant Professor of Research Ophthalmology

Image of Catherine Argyriou, PhD, MS
Is this your profile? Click to edit

Overview

My main research goal is to better understand the mechanisms of genetic diseases and to develop gene-based therapies to treat them, with a focus on peroxisomal disorders. Of particular interest are diseases that can affect multiple systems throughout the body, such as diseases that cause vision loss in conjunction with other organ involvement.

Publications

  • Using multiple modalities to confirm diagnosis in patients with suspected peroxisome biogenesis disorders. Mol Genet Metab. 2025 May; 145(1):109080.. View in PubMed
  • Try before you buy: Empirical comparison of base editing approaches. Mol Ther. 2025 Apr 02; 33(4):1310-1311.. View in PubMed
  • Spatial characterization of RPE structure and lipids in the PEX1-p.Gly844Asp mouse model for Zellweger spectrum disorder. J Lipid Res. 2025 Apr; 66(4):100771.. View in PubMed
  • Estimation of PEX1-mediated Zellweger spectrum disorder births and population prevalence by population genetics modeling. Genet Med Open. 2025; 3:103431.. View in PubMed
  • Zellweger Spectrum Disorder: Ophthalmic Findings from a New Natural History Study Cohort and Scoping Literature Review. Ophthalmology. 2023 12; 130(12):1313-1326.. View in PubMed
  • Peroxisomes : novel findings and future directions. Histochem Cell Biol. 2023 May; 159(5):379-387.. View in PubMed
  • Clinical, neuroradiological, and molecular characterization of patients with atypical Zellweger spectrum disorder caused by PEX16 mutations: a case series. Neurogenetics. 2022 04; 23(2):115-127.. View in PubMed
  • AAV-mediated PEX1 gene augmentation improves visual function in the PEX1-Gly844Asp mouse model for mild Zellweger spectrum disorder. Mol Ther Methods Clin Dev. 2021 Dec 10; 23:225-240.. View in PubMed
  • The biochemical basis of mitochondrial dysfunction in Zellweger Spectrum Disorder. EMBO Rep. 2021 10 05; 22(10):e51991.. View in PubMed
  • A longitudinal study of retinopathy in the PEX1-Gly844Asp mouse model for mild Zellweger Spectrum Disorder. Exp Eye Res. 2019 09; 186:107713.. View in PubMed
  • Zellweger spectrum disorder patient-derived fibroblasts with the PEX1-Gly843Asp allele recover peroxisome functions in response to flavonoids. J Cell Biochem. 2019 03; 120(3):3243-3258.. View in PubMed
  • Peroxisome biogenesis disorders. Transl Sci Rare Dis. 2016 Nov 07; 1(2):111-144.. View in PubMed
  • An enhanced immune response of Mclk1⁺/⁻ mutant mice is associated with partial protection from fibrosis, cancer and the development of biomarkers of aging. PLoS One. 2012; 7(11):e49606.. View in PubMed